Ostensibly this serves a purpose beyond the MAD incentive, having stocks of the virus on hand makes manufacturing the old style smallpox vaccine easier should the need ever arise in the future. As we saw with monkeypox last year there is much more limited capacity for more modern pox vaccines due to the more advanced manufacturing process and limited demand.